Microbion Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Microbion Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10594
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Microbion Corp (Microbion) is a clinical stage biopharmaceutical company that develops therapeutic products. The company develops products for the treatment of chronic infections and antibiotic-resistant infections. It develops environmentally responsible solutions to prevent microbial biofilms and the associated biofouling and biocorrosion. Microbion develops products using its bismuth-thiol platform technology. The company’s therapeutic pipeline includes BT compounds for the treatment of chronic and acute wound infections and post-surgical orthopedic infections. It also offers antimicrobial and antibiofilm therapeutics and medical device coating solutions. The company operates in the US and Canada. Microbion is headquartered in Bozeman, Montana, the US.

Microbion Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Microbion Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Microbion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Microbion Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Microbion Raises USD25 Million in Venture Financing 10
Microbion Raises US$0.1 Million In Venture Financing 11
Microbion Raises US$1.25 Million In Venture Financing 12
Partnerships 13
Microbion Enters into Agreement with Xizang Haisco Pharma 13
Equity Offering 14
Microbion Raises Funds through Private Placement of Shares 14
Microbion Corp – Key Competitors 15
Microbion Corp – Key Employees 16
Microbion Corp – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Microbion Corp, Pharmaceuticals & Healthcare, Key Facts 2
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Microbion Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Microbion Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Microbion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Microbion Raises USD25 Million in Venture Financing 10
Microbion Raises US$0.1 Million In Venture Financing 11
Microbion Raises US$1.25 Million In Venture Financing 12
Microbion Enters into Agreement with Xizang Haisco Pharma 13
Microbion Raises Funds through Private Placement of Shares 14
Microbion Corp, Key Competitors 15
Microbion Corp, Key Employees 16

List of Figures
Microbion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Microbion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Microbion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Microbion Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Sinar Mas Multiartha Tbk (SMMA):企業の財務・戦略的SWOT分析
    PT Sinar Mas Multiartha Tbk (SMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Pantheon Resources plc (PANR):企業の財務・戦略的SWOT分析
    Summary Pantheon Resources Plc (Pantheon Resources) is an oil and gas exploration and production company. It explores, develops and produces crude oil and natural gas resource properties. The company invests in oil and gas exploration and development. It operates hydrocarbon producing basins onshore …
  • Hemanext:製薬・医療:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • Duke Energy Corp (DUK):石油・ガス:M&Aディール及び事業提携情報
    Summary Duke Energy Corp (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also procures …
  • Saskatchewan Power Corp:企業の戦略的SWOT分析
    Saskatchewan Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Tata Motors Limited:企業の戦略・SWOT・財務分析
    Tata Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Genentech, Inc.:企業の戦略・SWOT・財務分析
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • MDU Resources Group, Inc.:企業の戦略・SWOT・財務情報
    MDU Resources Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary MDU Resources Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Moberg Pharma AB (MOB):製薬・医療:M&Aディール及び事業提携情報
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged …
  • Jordan Health Services Inc-製薬・医療分野:企業M&A・提携分析
    Summary Jordan Health Services Inc (Jordan) is a healthcare service provider that offers home healthcare services. The center offers personal care services, home management, pediatric services, skilled care and hospice services. It provides pediatric programs which include comprehensive care program …
  • Black Rock Mining Ltd (BKT):電力:M&Aディール及び事業提携情報
    Summary Black Rock Mining Ltd (BRML), formerly Green Rock Energy Ltd, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of graphite properties. It holds interest in Mahenge Graphite Project which includes high-grade flake g …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Rheinmetall AG:企業の戦略・SWOT・財務情報
    Rheinmetall AG - Strategy, SWOT and Corporate Finance Report Summary Rheinmetall AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cape Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Cape Plc (Cape), a subsidiary of Altrad Investment Authority Sas, is a critical industrial services provider. Its portfolio includes essential multi-disciplinary on-site, scaffolding and access, Insulation, coatings, integrated maintenance services, Project management, Tank repair, maintenan …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mitchells & Butlers plc:企業の戦略・SWOT・財務分析
    Mitchells & Butlers plc - Strategy, SWOT and Corporate Finance Report Summary Mitchells & Butlers plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • IDFC Ltd (IDFC):企業の財務・戦略的SWOT分析
    IDFC Ltd (IDFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sarah Cannon Research Institute LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sarah Cannon Research Institute LLC (SCRI) is a research institute that offers integrated cancer services. The institute conducts clinical research programs for advancing cancer therapies. Its services include blood cancer network, cancer care overview, cardiovascular research, contract rese …
  • Senzime AB (SEZI)-医療機器分野:企業M&A・提携分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆